Y-mAbs Therapeutics, Inc. - stock earnings
YMAB Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -0.1385000000 | - | - / 23.4 million | - |
YMAB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -988000 USD | 23.4 million USD |
| 2023Q3 | -7.7 million USD | 20.5 million USD |
| 2023Q2 | -6.3 million USD | 20.8 million USD |
| 2023Q1 | -5.1 million USD | 20.3 million USD |
| 2022Q4 | -401000 USD | 31.4 million USD |
| 2022Q3 | -29.0 million USD | 12.5 million USD |
| 2022Q2 | -42.3 million USD | 10.8 million USD |
| 2022Q1 | -28.4 million USD | 10.5 million USD |
| 2021Q4 | -36.9 million USD | 9.6 million USD |
| 2021Q3 | -28.9 million USD | 9.0 million USD |
| 2021Q2 | -22.9 million USD | 11.0 million USD |
| 2021Q1 | 33.4 million USD | 5.4 million USD |
| 2020Q4 | -19.9 million USD | 20.8 million USD |
| 2020Q3 | -32.8 million USD | ? USD |
| 2020Q2 | -40.4 million USD | ? USD |
| 2020Q1 | -26.2 million USD | ? USD |
| 2019Q4 | -23.1 million USD | ? USD |
| 2019Q3 | -23.9 million USD | ? USD |
| 2019Q2 | -18.0 million USD | ? USD |
| 2019Q1 | -15.9 million USD | ? USD |
| 2018Q4 | -14.1 million USD | ? USD |
| 2018Q3 | -11.4 million USD | ? USD |
| 2018Q2 | -10.3 million USD | ? USD |
| 2018Q1 | -7.5 million USD | ? USD |
| 2017Q4 | -9.3 million USD | ? USD |
| 2017Q3 | -3.8 million USD | ? USD |
| 2016Q4 | -17.1 million USD | ? USD |
YMAB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.4 million USD | 84.8 million USD |
| 2022 | -96.3 million USD | 65.3 million USD |
| 2021 | -56.3 million USD | 34.9 million USD |
| 2020 | -118.3 million USD | 20.8 million USD |
| 2019 | -78.9 million USD | ? USD |
| 2018 | -43.3 million USD | ? USD |
| 2017 | -19.2 million USD | ? USD |
| 2016 | -17.1 million USD | ? USD |
YMAB
Price: $17.24
52 week price:
Earnings Per Share: -0.49 USD
P/E Ratio: -29.09
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 294900
Market Capitalization: 629.1 million